## KMX: CarMax Inc - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 0.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($35.60)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Deadline Approaches: Kahn Swick & Foti, LLC Urges Action From CarMax, Inc. (KMX) Shareholders Sustaining $100,000 or More in Losses in Pending Lawsuit**
- Source: ABC4 Utah | 20251205T070835 | Neutral | Relevance: 100%
-  Kahn Swick & Foti, LLC, and partner Charles C. Foti, Jr., are urging CarMax, Inc. (KMX) shareholders who suffered losses of $100,000 or more to file lead plaintiff applications by January 2, 2026. This action stems from a securities class action lawsuit alleging CarMax failed to disclose material information, leading to a significant stock price drop after disappointing Q2 Fiscal Year 2026 financial results. Shareholders who purchased securities between June 20, 2025, and September 24, 2025, are affected.

**2. Pomerantz LLP Issues Important Reminder to CarMax, Inc. Shareholders – KMX**
- Source: Fox 59 | 20251204T230849 | Neutral | Relevance: 99%
-  Pomerantz LLP has announced a class action lawsuit against CarMax, Inc. (NYSE: KMX) for alleged securities fraud, following the company's Q2 2026 financial results which fell short of analyst expectations. Shareholders who acquired CarMax securities during the Class Period have until January 2, 2026, to apply to be Lead Plaintiff. The lawsuit stems from CarMax's reported EPS of $0.64 on $6.6 billion in sales, significantly lower than consensus estimates, leading to a 20.07% stock price drop.

**3. Shareholders SueWallSt in New Class Action Against CarMax, Inc. - Act Now**
- Source: FOX40 News | 20251205T200831 | Neutral | Relevance: 99%
-  A class-action lawsuit has been filed against CarMax, Inc. by investors who allegedly suffered financial losses due to securities fraud between June 20, 2025, and November 5, 2025. Levi & Korsinsky, a leading securities litigation firm, is representing the aggrieved shareholders and encourages affected investors to contact them.

**4. CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman**
- Source: PR Newswire | 20251205T081000 | Neutral | Relevance: 99%
-  Hagens Berman has filed a securities class action lawsuit against CarMax (NYSE: KMX), alleging that the company misled investors by failing to disclose that its Q1 2026 growth was a "temporary demand pull-forward" and that its loan portfolio (CAF) had undisclosed risks. The lawsuit claims these misrepresentations led to significant stock crashes after executives' statements and weak guidance. Investors who suffered losses during the Class Period (June 20, 2025, to November 5, 2025) are encouraged to contact Hagens Berman, with the lead plaintiff deadline set for January 2, 2026.

**5. Pomerantz LLP Issues Important Reminder to CarMax, Inc. Shareholders – KMX**
- Source: Louisiana First News | 20251204T230830 | Neutral | Relevance: 99%
- Pomerantz LLP has issued a reminder to shareholders of CarMax, Inc. (NYSE: KMX) about a class action lawsuit filed against the company for alleged securities fraud. The lawsuit stems from CarMax's Q2 2026 financial results, where the company reported earnings and sales significantly below consensus estimates, leading to a substantial drop in stock price. Investors who purchased CarMax securities during the class period have until January 2, 2026, to seek appointment as Lead Plaintiff.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $37 | $35 | +6% |
| 2025-11-18 | Wedbush | $40 | $40 | 0% |
| 2025-11-12 | Barclays | $28 | $0 | 0% |
| 2025-11-10 | Morgan Stanley | $35 | $56 | -38% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | In-Line |
| 2025-11-18 | Wedbush | reit | Neutral |
| 2025-11-12 | Barclays | init | Underweight |
| 2025-11-10 | Morgan Stanley | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-3.8%)
- Blackrock Inc.: 7.8% (+5.9%)
- State Street Corpora: 3.8% (-2.2%)
- Janus Henderson Grou: 3.3% (+1.0%)
- Diamond Hill Capital: 3.3% (-30.6%)

### Key Risks

1. Elevated short interest (11.4%): bears positioning against stock.
2. Long-term trend broken: trading 35.0% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.64 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.5x). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.9B |
| Beta | 1.29 |
| 52W Range | $30.26 - $91.25 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.64 |
| Forward P/E | 13.4 |
| Current P/E | 15.0 |
| YoY Growth | 12.0% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 5.7% to 0.7% (-5.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.3pp (needs >3.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.65x), long-term trend not supportive. MACD histogram positive (0.89), confirming momentum. RSI neutral at 52.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.71% (CS: 62) | Neutral |
| RSI_14 | 52.2 | Neutral |
| MACD Histogram | 0.89 | Bullish |
| vs SMA20 | 1.084x | Above |
| vs SMA50 | 0.961x | Below |
| vs SMA200 | 0.650x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $38.82
- **Stop Loss:** $35.60 (8.3% risk)
- **Target:** $42.04 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 310
- **Position Value:** $12,034.20
- **Portfolio %:** 12.03%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite persisting. Mixed earnings signals with industrial weakness (John Deere) offset by consumer/tech strength, while institutional flows show selective positioning rather than broad risk-off. Fed meeting in 9 days provides near-term catalyst but current data suggests status quo maintenance.*

### Earnings

**Next:** 2025-12-18 (Est: $0.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |
| 2024Q4 | $0.61 | $0.81 | +33.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*